HAYWARD, Calif.--(BUSINESS WIRE)--Jul. 13, 2009--
Impax Laboratories, Inc. (NASDAQ:IPXL) announced today that its
second quarter 2009 earnings will be released before the market opens on
Tuesday, August 4, 2009 and will be available on Impax’s Web site at www.impaxlabs.com.
The Company will host an earnings conference call and live webcast with
financial analysts at 11:00 a.m., Eastern time.
The live webcast will be accessible through the Investor Relations
section of the company's Web site, www.impaxlabs.com.
To access the call through a conference line, dial (877) 356-3814 (in
the U.S.) and (706) 758-0033 (international callers) beginning at least
10 minutes prior to the scheduled start of the call.
A replay of the conference call will be available for seven days shortly
after the call. To access the replay, dial (800) 642-1687 (in the U.S.)
and (706) 645-9291 (international callers). The access conference code
is 20084313.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. is a technology based specialty pharmaceutical
company applying its formulation expertise and drug delivery technology
to the development of controlled-release and specialty generics in
addition to the development of branded products. Impax markets its
generic products through its Global Pharmaceuticals division and markets
its branded products through the Impax Pharmaceuticals division.
Additionally, where strategically appropriate, Impax has developed
marketing partnerships to fully leverage its technology platform. Impax
Laboratories is headquartered in Hayward, California, and has a full
range of capabilities in its Hayward and Philadelphia facilities. For
more information, please visit the Company's Web site at: www.impaxlabs.com.
Source: Impax Laboratories, Inc.
Impax Laboratories, Inc.
Mark Donohue, Sr. Director Investor
Relations
(215) 933-3526
www.impaxlabs.com